0001104659-24-039129.txt : 20240326
0001104659-24-039129.hdr.sgml : 20240326
20240326181133
ACCESSION NUMBER: 0001104659-24-039129
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240326
DATE AS OF CHANGE: 20240326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobs John C
CENTRAL INDEX KEY: 0001820836
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 24785155
MAIL ADDRESS:
STREET 1: 630 W. GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
tm249879-3_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-01
0
0001000694
NOVAVAX INC
NVAX
0001820836
Jacobs John C
C/O NOVAVAX, INC.
700 QUINCE ORCHARD ROAD
GAITHERSBURG
MD
20878
1
1
0
0
President and CEO
0
Stock Option (Right to Buy)
5.39
2024-03-01
4
A
0
500000
0.00
A
2025-03-01
2034-03-01
Common Stock
500000
500000
D
Restricted Stock Units
2024-03-01
4
A
0
250000
0.00
A
Common Stock
250000
250000
D
Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 1, 2024 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 Grant Date, in each case subject to continued employment through such vesting date.
/s/ Mark J. Casey, Attorney-in-Fact
2024-03-26